Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?

Group 1 - Kiniksa Pharmaceuticals International, plc (KNSA) closed at $30.26, with an 8.5% gain over the past four weeks, and a mean price target of $41.14 suggests a 36% upside potential [1] - The mean estimate includes seven short-term price targets with a standard deviation of $7.45, indicating variability among analysts; the lowest estimate is $32.00 (5.8% increase), while the highest is $54.00 (78.5% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with a 26.6% increase in the Zacks Consensus Estimate for the current year, indicating potential upside for KNSA [11][12] Group 2 - KNSA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential for near-term upside [13] - The clustering of price targets with a low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement direction [9] - While price targets should not be the sole basis for investment decisions, they can provide a useful starting point for further research into the stock's fundamental drivers [10][14]